PRR19 activators are molecules that can impact gene expression indirectly through various mechanisms, which may result in altered levels of PRR19. These compounds do not act on PRR19 directly but can affect the protein through changes in the cellular environment, such as alterations in DNA methylation, histone acetylation, and activation of signaling pathways that culminate in transcriptional regulation. Molecules like 5-Azacytidine and RG108, which inhibit DNA methyltransferase, can induce a more transcriptionally permissive state, potentially resulting in the upregulation of genes like PRR19.
Furthermore, agents like beta-estradiol, which acts on nuclear hormone receptors, and dibutyryl-cAMP, which mimics the secondary messenger cAMP, exemplify how cellular signaling can lead to changes in the expression of genes like PRR19 by influencing the activity of transcription factors. In addition, the presence of histone deacetylase inhibitors such as Phenylbutyrate and Vorinostat highlights the importance of chromatin remodeling in gene expression.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can lead to demethylation of DNA, potentially enhancing the transcription of genes like PRR19. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
Another DNA methyltransferase inhibitor that can result in DNA demethylation and possibly upregulate the transcription of genes including PRR19. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
As an estrogen receptor agonist, it can activate estrogen-responsive elements in gene promoters, potentially upregulating genes like PRR19. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that activates PKA, leading to phosphorylation of transcription factors that may increase the transcription of PRR19. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $77.00 $166.00 $622.00 $5004.00 $32783.00 | 43 | |
A histone deacetylase inhibitor, possibly leading to increased expression of PRR19 by inducing a more open chromatin state. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
A PKC activator, which can influence transcription factors and pathways that may upregulate PRR19 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor, which can lead to enhanced transcription of various genes, potentially including PRR19. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A short-chain fatty acid that acts as a histone deacetylase inhibitor, potentially increasing the expression of genes like PRR19. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
A broad-spectrum histone deacetylase inhibitor that may lead to upregulation of gene expression, including that of PRR19. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
An essential mineral that can influence DNA-binding affinity of zinc finger transcription factors, possibly affecting the transcription of PRR19. | ||||||